INVU

Eastman, Swiss Eyewear Group collaborate to launch INVU 10th anniversary collection with Tritan Renew

Retrieved on: 
Tuesday, January 23, 2024
Hand, Conscience, Collection, INVU, Partnership, Freedom, Plastic, ISCC, Recycling

KINGSPORT, Tenn. and ZURICH, Jan. 23, 2024 /PRNewswire/ -- Eastman, a global specialty materials company, and Swiss Eyewear Group (SEG), a leading eyewear manufacturer, announce their partnership to celebrate the 10th anniversary of SEG's INVU eyewear collection .

Key Points: 
  • KINGSPORT, Tenn. and ZURICH, Jan. 23, 2024 /PRNewswire/ -- Eastman, a global specialty materials company, and Swiss Eyewear Group (SEG), a leading eyewear manufacturer, announce their partnership to celebrate the 10th anniversary of SEG's INVU eyewear collection .
  • The innovative eyewear collection features Eastman Tritan™ Renew in all the frames.
  • "With the launch of this new sustainable collection, INVU continues to deliver on its promise to offer cutting-edge eyewear while prioritizing sustainability."
  • "Eastman is glad to collaborate with Swiss Eyewear Group, a global leader in fashion eyewear known for its commitment to innovation and quality," said Rachel Oakley, eyewear segment leader for Eastman's plastics division.

Eastman, Swiss Eyewear Group collaborate to launch INVU 10th anniversary collection with Tritan Renew

Retrieved on: 
Tuesday, January 23, 2024
Hand, Conscience, Collection, INVU, Partnership, Freedom, Plastic, ISCC, Recycling

KINGSPORT, Tenn. and ZURICH, Jan. 23, 2024 /PRNewswire/ -- Eastman, a global specialty materials company, and Swiss Eyewear Group (SEG), a leading eyewear manufacturer, announce their partnership to celebrate the 10th anniversary of SEG's INVU eyewear collection .

Key Points: 
  • KINGSPORT, Tenn. and ZURICH, Jan. 23, 2024 /PRNewswire/ -- Eastman, a global specialty materials company, and Swiss Eyewear Group (SEG), a leading eyewear manufacturer, announce their partnership to celebrate the 10th anniversary of SEG's INVU eyewear collection .
  • The innovative eyewear collection features Eastman Tritan™ Renew in all the frames.
  • "With the launch of this new sustainable collection, INVU continues to deliver on its promise to offer cutting-edge eyewear while prioritizing sustainability."
  • "Eastman is glad to collaborate with Swiss Eyewear Group, a global leader in fashion eyewear known for its commitment to innovation and quality," said Rachel Oakley, eyewear segment leader for Eastman's plastics division.

Nuvo Group Ltd., an FDA-Cleared Leading Innovator in Pregnancy Care, to Become a Public Company Via Business Combination with LAMF Global Ventures Corp. I

Retrieved on: 
Friday, August 18, 2023
Women, Health, Parenting, Medical Devices, Baby, Maternity, Health Technology, Consumer, Other Health, Lumicel Animation Studios, Banner Health, Teaching, Partnership, Pregnancy, University, Herzog, Fox & Ne'eman, LAMF, Marketing, Parent, Health care, Prenatal care, White & Case, Multimedia, Acquisition, Patient, Sheba Medical Center, Capital, INVU, University of Pennsylvania Health System, FDA, Roth Capital Partners, Pharmaceutical industry, Nuvo, Meitar

Nuvo Group Ltd. (“Nuvo”), the creators of INVU by Nuvo™, an FDA-cleared remote pregnancy monitoring platform, and LAMF Global Ventures Corp.

Key Points: 
  • Nuvo Group Ltd. (“Nuvo”), the creators of INVU by Nuvo™, an FDA-cleared remote pregnancy monitoring platform, and LAMF Global Ventures Corp.
  • I (Nasdaq: LGVC, LGVCU, LGVCW) (“LAMF”), a publicly traded special purpose acquisition company, today announced that they have entered into a definitive business combination agreement.
  • Upon the closing of the transaction, which is expected in the first quarter of 2024, the combined public company is expected to be listed on Nasdaq.
  • We believe women’s health and pregnancy care has seen far too little investment and innovation to address these concerning trends.

Nuvo Group Ltd., A Leading FDA-Cleared Innovator in Pregnancy Care, and LAMF Global Ventures Corp I, Led by Chairman Jeffrey Soros and CEO Simon Horsman, Announce Intent to List Nuvo on Nasdaq Through a Business Combination

Retrieved on: 
Friday, April 28, 2023
Women, Pharmaceutical, Health, FDA, Medical Devices, Baby, Maternity, Health Technology, Consumer, Lumicel Animation Studios, Banner Health, Teaching, Partnership, Pregnancy, University, LAMF, Marketing, Parent, Prenatal care, Multimedia, LOI, Acquisition, OB, Sheba Medical Center, Capital, INVU, University of Pennsylvania Health System, Nursing, Commercial property, Nuvo

In connection with the closing of the contemplated transaction, the parties expect to apply to list on Nasdaq under the ticker “NUVO”.

Key Points: 
  • In connection with the closing of the contemplated transaction, the parties expect to apply to list on Nasdaq under the ticker “NUVO”.
  • If definitive agreements are executed as contemplated, the business combination is expected to close during the second half of 2023.
  • The parties have agreed on certain key terms of the proposed business combination and executed a non-binding letter of intent.
  • Jeffrey Soros and affiliates of 10X Capital have committed to make a financial investment in Nuvo in connection with the entry into a definitive agreement.

Nuvo Group and Sheba Medical Center's "Sheba BEYOND" Complete First Phase of Collaboration to Create a Virtual Obstetric Solution & Catalyze Research to Advance the Standard of Pregnancy Care

Retrieved on: 
Wednesday, August 17, 2022
FDA, Woman, Multimedia, Fast Company, Industry, CEO, Tel HaShomer, Technology, Pregnancy, Telehealth, CB Insights, Obstetrics, Top Ten, Research, Health, Sheba Medical Center, Gestational diabetes, Patient, Academic health science centre, TEL, View, Program, Parent, Partnership, Tuba City Regional Health Care Corporation, Nuvo, Thought, Physician, Goal, NEWSWEEK, Digital, Solution, Mother, Heart, Medicine, Contraindication, City, INVU, Medical device, Online shopping

TEL AVIV, Israel, Aug. 17, 2022 /PRNewswire/ -- Nuvo Group—the creators of INVU by Nuvo™, an FDA-approved remote pregnancy monitoring platform—announced today that it has completed the first phase of its collaboration agreement with Israel's Sheba Medical Center's "Sheba BEYOND", one of the Top Ten medical centers in the world (NEWSWEEK) and a global leader in biotechnological innovation.

Key Points: 
  • Participating physicians prescribed INVU to expectant mothers, who wore the sensor band from home during virtual visits.
  • For the next phase of the partnership, Nuvo and Sheba intend to work together to integrate the INVU platform into the hospital's standard of care protocols.
  • The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel Hashomer is generating global impact through its medical care, research and healthcare transformation.
  • Sheba BEYOND is the medical center's innovative virtual hospital, which offers a myriad of technological solutions for advanced patient care.

Philips and Nuvo Group Collaborate to Extend Prenatal Care Delivery Starting in Rural Colorado

Retrieved on: 
Tuesday, March 22, 2022
Health, Consumer, Hospitals, Women, Other Health, Baby, Maternity, General Health, CB, Contraindication, Organization, INVU, Academic health science centre, Diagnosis, Philips, Parent, NYSE, Digital health, News, NST, Woman, AEX, Nuvo, CEO, Health, White House, Technology, Industry, Digital, Medtech, Google Images, COVID-19, Physician, EUR, FDA, PHG, Patient, Medicine, Medical imaging, ROYAL PHILIPS, NUVO GROUP

Through the collaboration, Philips will support Nuvo in facilitating remote fetal monitoring pilot programs that focus on increasing access and adherence to prescribed care in remote areas, beginning with a pilot program in rural Colorado.

Key Points: 
  • Through the collaboration, Philips will support Nuvo in facilitating remote fetal monitoring pilot programs that focus on increasing access and adherence to prescribed care in remote areas, beginning with a pilot program in rural Colorado.
  • More than half (54 percent) of the counties in the USA offer very limited or no access to maternity care [1].
  • The USA continues to experience acute staffing shortages in medical care a challenge common in rural areas long before the COVID-19 pandemic.
  • Collaborating with Philips is an important step in our efforts to bring more comprehensive pregnancy care solutions to patients, providers and payers, said Kelly Londy, CEO of Nuvo Group.

Nuvo Group Presents New Data Supporting Expanded Capability of INVU™ Platform for Remote High-Risk Pregnancy Monitoring at Society of Maternal Fetal Medicine's 42nd Annual Pregnancy Meeting

Retrieved on: 
Thursday, February 3, 2022
Perelman School of Medicine at the University of Pennsylvania, Pregnancy, Patient, Parent, Workflow, Nuvo, University, INVU, MD, Contraindication, Machine learning, American Journal of Obstetrics and Gynecology, Technology, Academic health science centre, Maternal–fetal medicine, CDSS, Woman, Research, Obstetrics, CB Insights, Society, Fast Company, Uterine contraction, Digital, AJOG, Society for Maternal-Fetal Medicine, Industry, NST, FDA, Multimedia, TEL, American Journal, Medical imaging, Medicine, Birth control, Gynaecology

TEL AVIV, Israel, Feb. 3, 2022 /PRNewswire/ --Nuvo Group, a leader in modern maternal-fetal health, today presented new clinical data for INVUTM , the only FDA-cleared, prescription-initiated, remote pregnancy monitoring and management platform, at the Society for Maternal Fetal Medicine (SMFM)'s 42nd Annual Pregnancy Meeting.

Key Points: 
  • TEL AVIV, Israel, Feb. 3, 2022 /PRNewswire/ --Nuvo Group, a leader in modern maternal-fetal health, today presented new clinical data for INVUTM , the only FDA-cleared, prescription-initiated, remote pregnancy monitoring and management platform, at the Society for Maternal Fetal Medicine (SMFM)'s 42nd Annual Pregnancy Meeting.
  • INVU safely and accurately shifts the point of care and frees up time for both the doctor and the patient.
  • "Taken together, these capabilities have the potential to significantly improve pregnancy care for both the clinical care team and expectant mothers."
  • For more information and complete indications, contraindications, warnings and precautions along with instructions for use, visit: www.nuvocares.com .

Nuvo Group and Unified Women's Healthcare Announce Strategic Collaboration Agreement to Introduce a Remote Pregnancy Monitoring Platform Across Affiliate Care Centers

Retrieved on: 
Wednesday, January 12, 2022
CB Insights, Patient, Maternal–fetal medicine, Technology, Faculty of Occupational Medicine (United Kingdom), INVU, Fast Company, TEL, Medical director, OB, Nuvo, Sierra Vista, Arizona, Contraindication, Mother, CEO, Digital, Solution, Health care, PLC, Industry, Goal, Parent, NST, Urogynecology, Fertility, MD, Practice management, Academic health science centre, Multimedia, FDA, Willcox, OBGYN, Hospital, Organization, Partnership, Physician, Woman, Acquisition, Medicine, Birth control, Lucina, Genesis, Unified

Unified provides comprehensive, tech-enabled business services to over 2,500 providers across nearly 900 locations in 19 states and Toronto, Canada.

Key Points: 
  • Unified provides comprehensive, tech-enabled business services to over 2,500 providers across nearly 900 locations in 19 states and Toronto, Canada.
  • "By working with Nuvo, we will be able to better serve our patients by offering them convenient, remote pregnancy monitoring solutions while simultaneously alleviating in-office burden on our healthcare provider team."
  • Under the agreement, Unified intends to pilot the INVU platform to better manage at-risk pregnancies through the combined power of Unified's affiliates' advanced care delivery practices and scale and Nuvo's best-of-breed remote pregnancy monitoring platform.
  • "We're excited to partner with Nuvo to integrate their remote monitoring platform into our sophisticated maternal-fetal offerings," says Jack Feltz MD, Chief Medical Executive Officer of Unified.

Nuvo Group Partners with Charité - Universitätsmedizin Berlin to Establish a Remote Fetal Surveillance Protocol for Europe and Study Predictive Analytics on Preeclampsia Patients

Retrieved on: 
Wednesday, January 5, 2022
Contraindication, Nursing, CB Insights, Review, Research, Bed, Patient, Biomedical Research, Physician, TEL, Digital, Dentistry, Berlin Institute for Advanced Study, Department of Obstetrics and Gynecology (Massachusetts General Hospital), Pre-eclampsia, Education, Hypertension, Department, Biomarker, FDA, Woman, Partnership, Student, Fast Company, BIH, Population, INVU, Technology, Israel Innovation Authority, Fetal viability, Multimedia, Industry, Medical school, Academic health science centre, Parent, Pharmaceutical industry, Medical imaging, Nuvo, Charitable activities related to the COVID-19 pandemic, Obstetrics

In addition, the trial aims to identify predictive pathways for preeclamptic patients by extracting raw data from the INVU platform.

Key Points: 
  • In addition, the trial aims to identify predictive pathways for preeclamptic patients by extracting raw data from the INVU platform.
  • Hypertension, the key indicator of preeclampsia, occurs in up to 10% of pregnancies.
  • By pioneering a method to identify biomarkers for preeclampsia in its earliest stages, this partnership has a unique potential to improve outcomes for even the most at-risk patients.
  • For more information and complete indications, contraindications, warnings and precautions along with instructions for use, visit: www.nuvocares.com .

Leading Pregnancy App Babyscripts Announces Partnership With Nuvo Group to Deliver First-of-its-Kind Comprehensive Remote Pregnancy Care Solution

Retrieved on: 
Tuesday, October 12, 2021
Mental health, Digital health, Income, AI, Risk, Contraindication, Digital, Nuvo, Pregnancy, Obstetrics, Gestational hypertension, Parent, Data collection, Time, Mortality, Mother, INVU, FDA, Patient, Technology, CB Insights, Medical device, Birth control, Pharmaceutical industry

WASHINGTON, Oct. 12, 2021 /PRNewswire-PRWeb/ -- Babyscripts , the leading virtual care platform for managing obstetrics, announced today that they are entering into a collaboration with Nuvo Group, a company commercializing INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform.

Key Points: 
  • WASHINGTON, Oct. 12, 2021 /PRNewswire-PRWeb/ -- Babyscripts , the leading virtual care platform for managing obstetrics, announced today that they are entering into a collaboration with Nuvo Group, a company commercializing INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform.
  • Babyscripts Virtual Maternity Care solution allows providers to deliver risk-specific care to pregnant mothers at any time, in any place.
  • By integrating Nuvo's INVU technology into Babyscripts Virtual Maternity Care platform, Babyscripts' capabilities will extend to provide a more comprehensive remote pregnancy care platform that builds on Babyscripts existing solution for (i) patient education/engagement, (ii) remote monitoring tools, and (iii) improved care analytics to inform better outcomes.
  • Nuvo Group is committed to serving providers and expectant mothers by advancing pregnancy care with new technology, tools, and practices.